Trial intelligence / Profile preview

OPTIMISE: PRP for Tendon Regeneration in Partial Supraspinatus Tears

NCT07659600Not yet recruiting

Sponsor
NOVA University Lisbon
Start
Jun 2026
Primary completion
Jun 2029
01

Overview

Randomised, open-label trial of platelet-rich plasma in Supraspinatus tear (SST) (2 arms), sponsored by NOVA University Lisbon. Primary endpoint: Visual Analog Scale for Pain Intensity at 24 months. Planned start Jun 2026; status: not yet recruiting.

02

Drugs

platelet-rich plasma
03

Conditions

Supraspinatus tear (SST)

Beyond the preview

Go deeper on NCT07659600.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07659600.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call